ÂÜÀòÂÒÂ×

Neil has worked for 30 years in biopharma as a finance director and consultant. This includes over 25 years at Eli Lilly with key leadership roles as a CFO at affiliates in a start-up phase through clinical development. He spent the last 11 years as a financial lead on many significant Eli Lilly business development projects including licensing, equity transactions, and M&A from early research to post-launch collaborations. During his time with Eli Lilly, he held local assignments in Europe, China, and other global locations. Neil has an MBA from the Wharton School and a B.S. in Engineering from Imperial College, London.